Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood
Authors:
- S. MantovaniSMS. Mantovani
- R. GordonRGR. Gordon
- J.K. MacmawJMJ.K. Macmaw
- C.M.M. PflugerCPC.M.M. Pfluger
- R.D. HendersonRHR.D. Henderson
- P.G. NoakesPNP.G. Noakes
- P.A. McCombePMP.A. McCombe
- T.M. WoodruffTWT.M. Woodruff
- 1 November 2014
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 276 (1-2) , 213-218
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Protein aggregation in amyotrophic lateral sclerosisActa Neuropathologica, 2013
- Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALSJournal of Clinical Investigation, 2012
- The genetics and neuropathology of amyotrophic lateral sclerosisActa Neuropathologica, 2012
- Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral SclerosisPLOS ONE, 2012
- A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?CNS Neuroscience & Therapeutics, 2011
- Elevated Inflammatory Markers in a Group of Amyotrophic Lateral Sclerosis Patients from Northern IndiaNeurochemical Research, 2008
- UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALSAnnual Review of Neuroscience, 2004
- El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000
- C4, BF, C3 Allele Distribution and Complement Activity in Healthy Aged People and CentenariansThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 1999
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJournal of Clinical Investigation, 1970